- Report
- July 2023
- 210 Pages
Global
From €1912EUR$1,990USD£1,641GBP
- Report
- January 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- February 2024
- 202 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- March 2024
- 180 Pages
Global
From €3242EUR$3,374USD£2,783GBP
€3602EUR$3,749USD£3,092GBP
- Report
- March 2024
- 186 Pages
Global
From €3242EUR$3,374USD£2,783GBP
€3602EUR$3,749USD£3,092GBP
- Report
- March 2024
- 197 Pages
Global
From €3242EUR$3,374USD£2,783GBP
€3602EUR$3,749USD£3,092GBP
- Report
- September 2023
- 303 Pages
Global
From €4762EUR$5,130USD£3,950GBP
- Report
- April 2024
- 402 Pages
Global
From €4756EUR$4,950USD£4,083GBP
- Report
- January 2024
- 150 Pages
Global
From €4660EUR$4,850USD£4,000GBP
- Report
- August 2023
- 115 Pages
Global
From €2162EUR$2,250USD£1,856GBP
- Report
- August 2023
- 370 Pages
Global
From €2392EUR$2,490USD£2,054GBP
- Report
- February 2024
- 115 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- October 2023
- 178 Pages
Global
From €4708EUR$4,900USD£4,042GBP
- Report
- October 2023
- 189 Pages
Global
From €4708EUR$4,900USD£4,042GBP
- Report
- July 2023
- 110 Pages
Global
From €4324EUR$4,500USD£3,712GBP
- Report
- November 2023
- 167 Pages
Global
From €2402EUR$2,500USD£2,062GBP
- Report
- September 2023
- 194 Pages
Global
From €4756EUR$4,950USD£4,083GBP
- Report
- November 2023
- 29 Pages
United States
€2402EUR$2,500USD£2,062GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3315EUR$3,450USD£2,846GBP
- Report
- September 2023
- 87 Pages
Middle East, Africa
From €2834EUR$2,950USD£2,433GBP
The Adult Vaccine market is a segment of the larger Vaccine market, which focuses on providing immunizations to adults. Vaccines are used to protect adults from a variety of diseases, including influenza, hepatitis, and human papillomavirus. Vaccines are typically administered in a series of doses, and may require booster shots to maintain immunity. Vaccines are typically administered by healthcare professionals in a clinical setting, but some vaccines may be self-administered.
The Adult Vaccine market is highly competitive, with a variety of companies offering a range of products. Major players in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, and Johnson & Johnson. These companies offer a range of vaccines, including influenza, hepatitis, and human papillomavirus vaccines. Additionally, some companies offer combination vaccines, which provide protection against multiple diseases in a single dose. Show Less Read more